Background Patients with a history of anaphylaxis are at risk of future anaphylactic reactions.
Thus, secondary prevention measures are recommended for these patients to prevent or …

Background: Data on the long-term outcome of children after specific venom immunotherapy
(VIT) are limited. Therefore, we assessed sting recurrence and anaphylaxis relapse rates as …

Anaphylaxis may be lethal. The risk of dying depends on the combined effect of:▪ Factors
affecting the degree of allergic sensitization▪ Comorbidity affecting the reaction severity▪ …

Treatment of Hymenoptera venom allergy: an update : Current Opinion in Allergy and Clinical
Immunology Treatment of Hymenoptera venom allergy: an update : Current Opinion in Allergy …

Venom-specific immunotherapy (VIT) is considered for the treatment of patients with IgE-
mediated systemic allergic reactions (SARs) after developing a Hymenoptera venom allergy …

Wasp sting is not an uncommon incident. Around 56% to 94% of the population is stung at
least once in their lifetime by a member of the order Hymenoptera which includes wasps …

Background Venom immunotherapy (VIT) is highly effective in preventing allergic reactions
to insect stings, but the appropriate venom must be used to achieve clinical protection. In …

Background: Hazelnut allergy (HA) is one of the more common food allergies (FAs) in
Europe with a prevalence of 0.2%. The gold standard for diagnosing FA is oral food …

Background: Venom immunotherapy (VIT) is an established and effective treatment for
patients with Hymenoptera venom allergies. Especially during the build-up of VIT, systemic …

Zusammenfassung Hintergrund Die Hymenopterengift-spezifische Immuntherapie (HG-SIT)
ist sehr wirksam. Allerdings können trotz HG-SIT Patienten noch systemische …